Virginia Drug Discovery Consortium
The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:
To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.
To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.
To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.
After 22 years at Virginia Tech, executive committee chair Paul Carlier is joining the University of Illinois Chicago's collaborative drug discovery center as their new director. He will also serve a joint appointment in the Departments of Pharmaceutical Sciences and...
Elizabeth R. Sharlow, Professor of Research, Pharmacology in University of Virginia's School of Medicine discusses UVA's Fiske Drug Discovery Laboratory where impactful pharmacological research occurs every day. UVA graduate and undergraduate students are learning to...
Charlottesville, Virginia - February 2022 KeViRx, Inc. (“KeViRx”) has been selected to join Blue Knight, a joint initiative between Johnson & Johnson Innovation – JLABS and the Biomedical Advanced Research and Development Authority (BARDA), a component of the U.S....
Want to work with us?
If you are interested in supporting this initiative, please contact us.